TR199801702T2 - Yabanci DNA ihtiva eden parapoksvirüsler, bunlarin hazirlanmasi ve asilarda kullanimi. - Google Patents

Yabanci DNA ihtiva eden parapoksvirüsler, bunlarin hazirlanmasi ve asilarda kullanimi.

Info

Publication number
TR199801702T2
TR199801702T2 TR1998/01702T TR9801702T TR199801702T2 TR 199801702 T2 TR199801702 T2 TR 199801702T2 TR 1998/01702 T TR1998/01702 T TR 1998/01702T TR 9801702 T TR9801702 T TR 9801702T TR 199801702 T2 TR199801702 T2 TR 199801702T2
Authority
TR
Turkey
Prior art keywords
parapoxviruses
vaccines
preparation
foreign dna
containing foreign
Prior art date
Application number
TR1998/01702T
Other languages
English (en)
Inventor
Schmeer Norbert
Strube Walter
Buttner Math�As
Rziha Hans-Joach�M
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19639601A external-priority patent/DE19639601A1/de
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of TR199801702T2 publication Critical patent/TR199801702T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Bu bulus, genomlarinda, yabanci kalitim bilgisi biçiminde silinmeleri ya da girmeleri tasiyan ve kalitim bilgilerini ihtiva eden rekombinant biçimde hazirlanmis parapoksvirüslere, bu gibi konstruktlarin hazirlanmasina ve bunlarin asilarda kullanimina iliskindir.
TR1998/01702T 1996-02-28 1997-02-17 Yabanci DNA ihtiva eden parapoksvirüsler, bunlarin hazirlanmasi ve asilarda kullanimi. TR199801702T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19607458 1996-02-28
DE19639601A DE19639601A1 (de) 1996-02-28 1996-09-26 Parapockenviren, die Fremd-DNA enthalten, ihre Herstellung und ihre Verwendung in Impfstoffen

Publications (1)

Publication Number Publication Date
TR199801702T2 true TR199801702T2 (tr) 1998-12-21

Family

ID=26023280

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01702T TR199801702T2 (tr) 1996-02-28 1997-02-17 Yabanci DNA ihtiva eden parapoksvirüsler, bunlarin hazirlanmasi ve asilarda kullanimi.

Country Status (19)

Country Link
US (1) US6365393B1 (tr)
EP (1) EP0886679B1 (tr)
JP (1) JP2000507092A (tr)
CN (1) CN1217027A (tr)
AT (1) ATE364090T1 (tr)
AU (1) AU718141B2 (tr)
BR (1) BR9707785A (tr)
CA (1) CA2247336C (tr)
DE (1) DE59712852D1 (tr)
DK (1) DK0886679T3 (tr)
ES (1) ES2287949T3 (tr)
HU (1) HUP9901035A3 (tr)
IL (1) IL125797A0 (tr)
NO (1) NO983946L (tr)
NZ (1) NZ331556A (tr)
PL (1) PL190401B1 (tr)
SK (1) SK120098A3 (tr)
TR (1) TR199801702T2 (tr)
WO (1) WO1997032029A1 (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9708401A (pt) * 1996-03-29 2000-01-04 Univ Otago Vetores de vìrus de para-varìola
DK2016951T3 (da) * 1998-03-17 2012-09-24 Genentech Inc VEGF- og BMP1-homologe polypeptider
EP1126863B1 (en) * 1998-11-02 2006-05-03 Ludwig Institute For Cancer Research Vascular endothelial growth factor-like protein from orf virus nz10 binds and activates mammalian vegf receptor-2
CN1455674B (zh) * 2000-07-11 2019-03-29 艾库里斯有限及两合公司 绵羊副痘病毒菌株用于制备抗病毒药物和抗癌药物的用途
US6752995B2 (en) * 2002-04-15 2004-06-22 Board Of Regents, The University Of Texas System Nucleic acid and polypeptide sequences useful as adjuvants
WO2003049683A2 (en) 2001-12-07 2003-06-19 Bayer Pharmacueticals Corporation Use of parapox b2l protein to treat cancer and modify immune responses
JP4897677B2 (ja) * 2004-07-13 2012-03-14 アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト Ｈｉｖ／ａｉｄｓの処置用の他の抗ウイルス剤と組み合わせたパラポックスウイルス
EA201270764A1 (ru) * 2010-04-29 2013-06-28 Римзер Фарма Гмбх Парапоксвирус, экспрессирующий vp60 главный белок капсида вируса геморрагического заболевания кроликов
AU2011254315B2 (en) 2010-05-21 2015-05-14 Zoetis Services Llc Parapoxvirus vectors containing rabies virus antigen
EP2595652A1 (en) 2010-07-20 2013-05-29 Ah Usa 42 Llc Parapoxvirus vectors
CA2879443A1 (en) 2012-07-19 2014-01-23 Zoetis Llc Bovine influenza virus compositions
AU2013295770A1 (en) 2012-07-27 2015-01-29 Zoetis Services Llc Tick toxin compositions
DE102015111756A1 (de) * 2015-07-20 2017-01-26 Eberhard Karls Universität Tübingen Medizinische Fakultät Rekombinanter Orf-Virus-Vektor
CA2995101A1 (en) 2015-08-14 2017-02-23 Zoetis Services Llc Mycoplasma bovis compositions
US11013798B2 (en) 2016-03-21 2021-05-25 South Dakota Board Of Regents Orf virus-based platform for vaccine delivery
MX2020009262A (es) 2018-03-07 2021-01-08 Transgene Vectores de parapoxvirus.
WO2024062098A1 (en) 2022-09-23 2024-03-28 Transgene Recombinant pseudocowpox virus encoding an interleukin-12

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DK0758397T3 (da) * 1994-04-29 2005-10-10 Baxter Healthcare Sa Rekombinante poxvira med fremmede polynucleotider i essentielle regioner

Also Published As

Publication number Publication date
ATE364090T1 (de) 2007-06-15
BR9707785A (pt) 1999-07-27
SK120098A3 (en) 1999-03-12
IL125797A0 (en) 1999-04-11
DK0886679T3 (da) 2007-09-24
PL328870A1 (en) 1999-03-01
CA2247336C (en) 2008-06-17
DE59712852D1 (de) 2007-07-19
US6365393B1 (en) 2002-04-02
AU718141B2 (en) 2000-04-06
AU1725797A (en) 1997-09-16
PL190401B1 (pl) 2005-12-30
NO983946L (no) 1998-10-22
EP0886679B1 (de) 2007-06-06
CN1217027A (zh) 1999-05-19
HUP9901035A3 (en) 2001-01-29
EP0886679A1 (de) 1998-12-30
NZ331556A (en) 2000-05-26
HUP9901035A2 (hu) 1999-07-28
NO983946D0 (no) 1998-08-27
JP2000507092A (ja) 2000-06-13
ES2287949T3 (es) 2007-12-16
WO1997032029A1 (de) 1997-09-04
CA2247336A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
TR199801702T2 (tr) Yabanci DNA ihtiva eden parapoksvirüsler, bunlarin hazirlanmasi ve asilarda kullanimi.
TR200806259T2 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
TR199801418T2 (tr) Rekombinant asi vektörleri karisimi.
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
CY1106350T1 (el) Εμβολιο φυματιωσης
ATE328896T1 (de) Faktor viii vom schwein und hybriden
DE69421971D1 (de) Empfänger und Empfängerverfahren
EP0713530A4 (en) HIGH-LEVEL EXPRESSION, PURIFICATION AND FOLDING OF GROUP B PORINE PROTEINS FROM NEISSERIA MENINGITIDIS EXTERNAL MEMBRANE
ATE328068T1 (de) Papillomavirus vakzine
DE69713711D1 (de) Nanoemulsion auf Basis von nichtionischen und kationischen, amphiphilen Lipiden und ihre Verwendung
TR28091A (tr) Bulusun valfini ve kazanini iceren, seyyar müsterek jeneratör tertibati.
HUP0000302A2 (hu) OB fúziós protein készítmények és módszerek
BRPI9912663B8 (pt) vacina contra cáncer e polipeptìdeo.
MY150893A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
EP0783527A4 (en) PROTEASE CATHEPSINE O2
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
CA2437201A1 (en) Methods and compositions useful for stimulating an immune response
BR9607583B1 (pt) plasmìdios procarióticos recombinantes.
FR2766193B1 (fr) Polypeptide chimerique comprenant le fragment b de la toxine shiga et des peptides d'interet therapeutique
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
DE50110475D1 (de) Lichtschutz- bzw. Pflegezubereitungen mit einem Gehalt an DNA-Reparaturenzymen
DK0892054T3 (da) Clostridium perfringens-vaccine
DE69732789D1 (de) Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden
YU36698A (sh) Parapoks-virusi koji sadrže stranu dnk, njihovo dobijanje i njihova primena u vakcinama